Equine hydrallantois is associated with impaired angiogenesis in the placenta

Placenta. 2020 Apr:93:101-112. doi: 10.1016/j.placenta.2020.03.001. Epub 2020 Mar 5.

Abstract

Introduction: Hydrallantois is the excessive accumulation of fluid in the allantoic cavities during the last trimester of pregnancy, leading to abdominal wall hernias, cardiovascular shock, abortion, and dystocia. It has been postulated that hydrallantois is associated with structural and/or functional changes in the chorioallantoic membrane. In the present study, we hypothesized that angiogenesis is impaired in the hydrallantoic placenta.

Method: Capillary density in the hydrallantoic placenta was evaluated in the chorioallantois via immunohistochemistry for Von Willebrand Factor. Moreover, the expression of angiogenic genes was compared between equine hydrallantois and age-matched, normal placentas.

Results: In the hydrallantoic samples, edema was the main pathological finding. The capillary density was significantly lower in the hydrallantoic samples than in normal placentas. The reduction in the number of vessels was associated with abnormal expression of a subset of angiogenic and hypoxia-associated genes including VEGF, VEGFR1, VEGFR2, ANGPT1, eNOS and HIF1A. We believe that the capillary density and the abnormal expression of angiogenic genes leads to tissue hypoxia (high expression of HIF1A) and edema. Finally, we identified a lower expression of genes associated with steroidogenic enzyme (CYP19A1) and estrogen receptor signaling (ESR2) in the hydrallantoic placenta.

Discussion: Based on the presented data, we believe that formation of edema is due to disrupted vascular development (low number of capillaries) and hypoxia in the hydrallantoic placenta. The edema leads to further hypoxia and consequently, causes an increase in vessel permeability which leads to a gradual increase in interstitial fluid accumulation, resulting in an insufficient transplacental exchange rate and accumulation of fluid in the allantoic cavity.

Keywords: Angiogenesis; Equine; Fetal placenta; Hydrallantois; Hydrops.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allantois / metabolism
  • Allantois / pathology
  • Animals
  • Female
  • Horse Diseases* / genetics
  • Horse Diseases* / pathology
  • Horse Diseases* / physiopathology
  • Horses
  • Microvascular Density
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / pathology*
  • Neovascularization, Pathologic / physiopathology
  • Placenta / blood supply*
  • Placenta / metabolism
  • Placenta / pathology
  • Placenta / physiopathology
  • Placenta Diseases* / genetics
  • Placenta Diseases* / pathology
  • Placenta Diseases* / physiopathology
  • Placenta Diseases* / veterinary
  • Polyhydramnios / etiology
  • Polyhydramnios / pathology*
  • Polyhydramnios / physiopathology
  • Polyhydramnios / veterinary
  • Pregnancy
  • Pregnancy, Animal*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / genetics
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / genetics
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2